| |
| |
|
| Insider
Information: |
Shaff Eric D. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
135,321 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$150,206 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
135,321 |
|
|
| Total
Value |
$150,206 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seres Therapeutics, Inc. |
MCRB |
|
2024-02-16 |
135,321 |
2016-03-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MCRB |
Seres Therapeutics, Inc. |
CEO and President |
• • – |
2024-02-16 |
4 |
AS |
$1.08 |
$12,473 |
D/D |
(11,549) |
135,321 |
0 |
% |
|
| MCRB |
Seres Therapeutics, Inc. |
CEO and President |
• • – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
146,870 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CEO and President |
• • – |
2023-10-30 |
4 |
AS |
$1.35 |
$11,545 |
D/D |
(8,552) |
115,620 |
0 |
% |
|
| MCRB |
Seres Therapeutics, Inc. |
CEO and President |
• • – |
2023-10-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,838 |
124,172 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CEO and President |
• • – |
2022-07-05 |
4 |
A |
$3.15 |
$200,000 |
D/D |
63,492 |
96,334 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CEO and President |
• – – |
2020-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
32,842 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2019-01-28 |
4 |
S |
$5.75 |
$25,188 |
D/D |
(4,378) |
12,842 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2019-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,000 |
17,220 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-01-26 |
4 |
S |
$11.02 |
$30,636 |
D/D |
(2,780) |
5,220 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-06-30 |
4 |
AS |
$29.54 |
$133,905 |
D/D |
(4,533) |
0 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-06-30 |
4 |
OE |
$7.79 |
$35,312 |
D/D |
4,533 |
4,533 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-06-28 |
4 |
AS |
$28.85 |
$48,093 |
D/D |
(1,667) |
0 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-06-28 |
4 |
OE |
$7.79 |
$12,986 |
D/D |
1,667 |
1,667 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-06-27 |
4 |
AS |
$28.00 |
$93,352 |
D/D |
(3,334) |
0 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-06-27 |
4 |
OE |
$7.79 |
$25,972 |
D/D |
3,334 |
3,334 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-04-04 |
4 |
OE |
$7.79 |
$51,165 |
D/D |
6,568 |
6,568 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-04-04 |
4 |
AS |
$28.85 |
$189,487 |
D/D |
(6,568) |
0 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-03-31 |
4 |
AS |
$25.13 |
$201,569 |
D/D |
(7,663) |
0 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-03-31 |
4 |
OE |
$7.79 |
$59,695 |
D/D |
7,663 |
7,663 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-03-28 |
4 |
AS |
$24.07 |
$131,735 |
D/D |
(5,473) |
0 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
CFO and EVP |
• – – |
2016-03-28 |
4 |
OE |
$7.79 |
$42,635 |
D/D |
5,473 |
5,473 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
